Inavir Pharmatech Private Limited, a active private limited company, was established on 28 July 2011 in Hyderabad, Telangana, India. Engaging in chemical distribution & retail within the trade sector, it holds CIN: U24232TG2011PTC075701. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹9.74 M.
It upholds a compliant status. Its leadership includes Sujatha Tanniru (Additional Director), Abdul Mukaram Mohammed (Director), Vijay Bhaskar Bandla (Managing Director). Past directors included Bobba Dharma Teja, Jagadeshwar Rao Madhavaram, Vijay Bhaskar Bandla. It holds ₹7.49 M open charges and ₹8.65 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No: 7-1-643 & 643/1, Bhanu Enclave, Flat No.119, Sundar Nagar,Besides Esi Hospital, S.R N, Agar,, Hyderabad, Telangana, 500038.
U24232TG2011PTC075701
075701
28 July 2011
₹1.50 Cr
₹9.74 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Inavir Pharmatech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujatha Tanniru | Additional Director | 22 Jul 2015 | Current |
| Abdul Mukaram Mohammed | Director | 30 Dec 2023 | Current |
| Vijay Bhaskar Bandla | Managing Director | 28 Jul 2011 | Current |
| Krutika Misra | Director | 30 Sep 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Sep 2012 | Past |
| Pramod Abcsdd | Director | 08 Oct 2015 | Past |
| Pramod Abcsdd | Director | 06 Oct 2011 | Past |
| Pramod Abcsdd | Director | 02 Jun 2013 | Past |
| Pramod Abcsdd | Director | 01 Sep 2012 | Past |
| Pramod Abcsdd | Director | 01 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Inavir Pharmatech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.65% decrease. The company also saw a substantial fall in profitability, with a 33.67% decrease in profit. The company's net worth moved up by a moderate rise of 7.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Inavir Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,486,539.00
₹86,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Apr 2022 | Others | ₹7.49 M | Open |
| 20 Jul 2019 | Others | ₹8.15 Cr | Satisfied |
| 29 Mar 2016 | Others | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Inavir Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Inavir Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inavir Pharmatech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 20 Jul 2019 via Charge ID 100276798 with Others was fully satisfied on 12 Mar 2025. was documented.
Progress on Inavir Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Inavir Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Abdul Mukaram Mohammed was appointed as a Director was appointed as a Director on 30 Dec 2023 & has been associated with this company since 1 year 11 months . was completed.
Progress on A charge with Others amounted to Rs. 0.75 Cr with Charge ID 100594891 was registered on 19 Apr 2022. was documented.
The activity A charge with Others of Rs. 8.15 Cr registered on 20 Jul 2019 with Charge ID 100276798 was modified on 04 Jan 2021. was completed.
The CIN of Inavir Pharmatech Private Limited is U24232TG2011PTC075701.
Inavir Pharmatech Private Limited is headquartered at H.No: 7-1-643 & 643/1, Bhanu Enclave, Flat No.119, Sundar Nagar,Besides Esi Hospital, S.R N, Agar,, Hyderabad, Telangana, 500038.
Inavir Pharmatech Private Limited was incorporated on 28 July 2011.
The current directors of Inavir Pharmatech Private Limited are
The primary industry of Inavir Pharmatech Private Limited is Trade.
Inavir Pharmatech Private Limited is unlisted.
The authorized capital of Inavir Pharmatech Private Limited is ₹1.50 Cr, and the paid-up capital is ₹9.74 M.
The compliance status of Inavir Pharmatech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX